More Advanced Cancer at Presentation Possible Effect of Pandemic
FRIDAY, April 2, 2021 (HealthDay News) — Physicians report that patients are presenting with...
Read More
Hematology/Oncology
Screening May Improve Early Detection for Melanoma-Prone
FRIDAY, April 2, 2021 (HealthDay News) — For melanoma-prone families, reduced melanoma...
Read More
More Cases of Blood Clots Linked to AstraZeneca COVID-19 Vaccine
FRIDAY, April 2, 2021 (HealthDay News) — British regulators say they have identified 30...
Read More
Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer
THURSDAY, April 1, 2021 (HealthDay News) — Among patients with resected esophageal or...
Read More
Endocrine Society, March 20-23
The annual meeting of the Endocrine Society was held virtually this year from March 20 to 23 and...
Read More
FDA: Complications Up for Two Brands of Surgical Mesh Used in Breast Reconstruction
THURSDAY, April 1, 2021 (HealthDay News) — FlexHD and AlloMax brands of acellular surgical...
Read More
Clinical Preventive Service Use Varies Across the United States
THURSDAY, April 1, 2021 (HealthDay News) — Use of recommended clinical preventive services...
Read More
COVID-19 Was Third Leading Cause of Death in US in 2020
THURSDAY, April 1, 2021 (HealthDay News) — COVID-19 was reported as an underlying or...
Read More
Expanding Lynch Syndrome Screening to Include Ovarian Cancer
Although the benefits of universal screening for colorectal cancer (CRC) and endometrial cancer...
Read More
Community Exposures Tied to SARS-CoV-2 Seropositivity in HCWs
WEDNESDAY, March 31, 2021 (HealthDay News) — Community exposures, but not workplace factors,...
Read More
Tobacco Use Up During Early COVID-19 Lockdown
WEDNESDAY, March 31, 2021 (HealthDay News) — Existing smokers or users of electronic...
Read More
A male with primary accessory breast carcinoma in an axilla is strongly suspected of having hereditary breast cancer.
We herein report on a male with primary accessory breast cancer in an axilla. A 75-year-old man...
Read More
LRRK2 inhibition potentiates PARP inhibitor cytotoxicity through inhibiting homologous recombination-mediated DNA double strand break repair.
PARP inhibitors induce DNA lesions, the repair of which are highly dependent on homologous...
Read More
Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction.
Synthetic lethality is a successful strategy employed to develop selective chemotherapeutics...
Read More
Obesity Tied to Increased Mortality Overall in Patients With Cancer
TUESDAY, March 30, 2021 (HealthDay News) — For patients with cancer, obesity is associated...
Read More
First Cell-Based Gene Therapy Approved for Multiple Myeloma
TUESDAY, March 30, 2021 (HealthDay News) — Abecma (idecabtagene vicleucel), a chimeric...
Read More
Outcomes for Complex GI Cancer Surgery Better at Top-Ranked Hospitals
MONDAY, March 29, 2021 (HealthDay News) — For patients who require complex gastrointestinal...
Read More
Actinic Keratosis Diagnosis Ups Cumulative Risk for Skin Cancer
MONDAY, March 29, 2021 (HealthDay News) — The annual increase in risk for cutaneous squamous...
Read More
IRS: COVID-19 PPE Tax-Deductible
MONDAY, March 29, 2021 (HealthDay News) — Faces masks, hand sanitizer, and disinfecting...
Read More
Down-regulation of long non-coding RNA antisense non-coding RNA in the INK4 locus suppresses OVCAR-3 cells proliferation and induction of apoptosis by Wnt/β -catenin.
Ovarian cancer is a lethal gynecological malignancy. Long non-coding RNA antisense non-coding RNA...
Read More